Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Biological Chemistry
Genzyme Partners in new Malaria Effort
by Lisa M. Jarvis
November 24, 2008
| A version of this story appeared in
Volume 86, Issue 47
Genzyme has joined forces with the International Center for Genetic Engineering & Biotechnology to find new treatments for neglected diseases. ICGEB, a nonprofit with components in India, South Africa, and Italy, will not have to pay royalties to commercialize any drug for neglected diseases that comes out of the collaboration. Their first project will pursue new ways to target two parasites that cause around 65% of the malaria cases in India. Scientists from each organization will likely spend time in the other's labs, in New Delhi and Waltham, Mass.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter